About Blue Heron Bio
Blue Heron Bio is a Healthcare company based in Bothell (United States) founded in 1999, and was acquired by Eurofins Genomics in August 2019. Gene synthesis and sequencing services are provided using proprietary technology. Blue Heron Bio has raised $3.68 million across 1 funding round from investors including OriGene, Eurofins Genomics and Life Technologies. Blue Heron Bio offers products and services including Gene Synthesis, Gene Fragments, Plasmid Prep, and Oligo Synthesis. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Technology Platforms. Its legal entity is Blue Heron Biotech, LLC. Its competitors include Avidity Biosciences, Poseida Therapeutics and Senti Biosciences; 3 of its 3 listed competitors have raised funding.
Company details
Blue Heron Bio was founded in 1999 and is based in Bothell, United States. Operations center on biotechnology, with services focused on DNA design, gene synthesis, and sequencing. The proprietary Genemaker Technology platform is utilized to handle complex sequences, including large genes, hairpins, repeats, and GC-rich DNA. These capabilities support research and development in the life sciences sector.
- Headquarters Bothell, United States
- Stage Acquired
- SectorsHealthcare
- Website blueheronbio.com
- Social LinkedIn X Facebook
- Acquired by Eurofins Genomics (Aug 2019)
- Legal Name Blue Heron Biotech, Llc
- Total Equity Funding$3.68M (USD)
in 1 rounds
- Latest Funding Round$3.68M (USD), Series D
Jan 2007
- InvestorsOriGene
& 4 more
- Acquired by
Products & Services of Blue Heron Bio
Blue Heron Bio offers a comprehensive portfolio of products and services, including Gene Synthesis, Gene Fragments, Plasmid Prep, and Oligo Synthesis.
Service for custom gene creation with fast turnaround for research.
Rapid production of DNA fragments for various applications.
Preparation of high-quality plasmids for experimental use.
Synthesis of oligonucleotides for research and sequencing.
Funding Insights of Blue Heron Bio
Blue Heron Bio has successfully raised a total of $3.68M through 1 strategic funding round. The most recent funding activity was a Series D round of $3.68 million completed in January 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.68M
- Total Rounds 1
- Last Round Series D — $3.68M
- First Round $3.68M
(Jan 2007)
- Investors Count 3
All 1 funding rounds of Blue Heron Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2007 | $3.68M | Series D | – | – |
5 investors in total: 5 institutional.
Investors in Blue Heron Bio
Blue Heron Bio has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include OriGene, Eurofins Genomics and Life Technologies.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| taraval.com | ||||
| integraventures.net | ||||
Tools and technologies for biotech and biopharma research were supplied. | 1983 | lifetechnologies.com | Carlsbad, United States | |
Proteins, antibodies, and molecular tools are manufactured for research applications. | 1996 | origene.com | Rockville, United States | |
Genomics products and sequencing services are provided globally. | 1990 | eurofinsgenomics.com | Bengaluru, India |
Investor details for Blue Heron Bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Blue Heron Bio
1 people are tracked at Blue Heron Bio (1 in leadership).
| Name | Role | Group |
|---|---|---|
Isaiah Chuang | President | Leadership |
Complete people profiles for Blue Heron Bio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Blue Heron Bio
4 dated milestones of Blue Heron Bio across 20 years, from founding to its latest funding, stage changes and deals.
- Founded Blue Heron Bio is founded.
- Funding First funding round of $3.7M.
- Exit Acquired by OriGene.
- Exit Acquired by Eurofins Genomics.
Competitors of Blue Heron Bio
Blue Heron Bio has 3 listed competitors in our database, 3 of them funded. They include Avidity Biosciences, Poseida Therapeutics and Senti Biosciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| poseida.com | 2015 | San Diego, United States | $323.78M | 259 | Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies | |
| sentibio.com | 2016 | San Francisco, United States | $158M | Cell-based therapies for cancer treatment are developed. |
Detailed competitors of Blue Heron Bio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Blue Heron Bio
The website of Blue Heron Bio (blueheronbio.com) receives about 1.9K visits a month.
- Monthly visits1.9K
▲ 63.5% vs previous month
Websites whose visitors overlap most with Blue Heron Bio. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| idtdna.com | 100% | 505.8K | #85,096 | View details | |
entelechon.com | entelechon.com | 95% | – | ||
| eurogentec.com | 81% | 40.4K | #771,641 | View details | |
qualbio.com | qualbio.com | 81% | #10,964,115 | – | |
| biopeptide.com | 81% | 1.9K | #8,179,515 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 19 similar websites and full traffic analytics for Blue Heron Bio
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 19 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Blue Heron Bio (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Blue Heron Bio
Complete news archive for Blue Heron Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Blue Heron Bio
Blue Heron Bio was founded in 1999 and raised its 1st funding round 8 years after it was founded.
Blue Heron Bio is headquartered in Bothell, United States. It is registered at Bothell, Washington, United States.
Blue Heron Bio is a funded company, having raised a total of $3.68M across 1 funding round to date. The company's 1st funding round was a Series D of $3.68M, raised on Jan 2007.
Blue Heron Bio was founded in 1999 and is based in Bothell, United States. Operations center on biotechnology, with services focused on DNA design, gene synthesis, and sequencing. The proprietary Genemaker Technology platform is utilized to handle complex sequences, including large genes, hairpins, repeats, and GC-rich DNA. These capabilities support research and development in the life sciences sector.
Blue Heron Bio's top competitors include Avidity Biosciences, Senti Biosciences and Poseida Therapeutics.
Blue Heron Bio offers Gene Synthesis, Gene Fragments, Plasmid Prep, and Oligo Synthesis.
Blue Heron Bio has 5 investors. Key investors include OriGene, Eurofins Genomics, Life Technologies, Integra Ventures, and Taraval Associates.
Blue Heron Bio operates through Blue Heron Biotech, Llc.
Yes. Blue Heron Bio was acquired by Eurofins Genomics in August 2019.